These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20172348)

  • 1. Comparison of dissolution properties of 2 enteric-coated formulations containing mycophenolate sodium: Myfortic vs Femulan.
    Esquivel A; González-Ramírez R; Alberú J; Gracida C; Medeiros M; Castañeda-Hernández G
    Transplant Proc; 2010; 42(1):353-6. PubMed ID: 20172348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft.
    Neumann I; Fuhrmann H; Kanzler M; Fang IF; Jaeger A; Graf H; Bayer P; Kovarik J
    Expert Opin Pharmacother; 2008 Apr; 9(6):879-86. PubMed ID: 18377332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteric-coated mycophenolate sodium.
    Gabardi S; Tran JL; Clarkson MR
    Ann Pharmacother; 2003 Nov; 37(11):1685-93. PubMed ID: 14565799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myfortic (mycophenolate sodium) delayed-release tablets.
    Qureshi A; Scheinfeld N
    Dermatol Online J; 2008 Aug; 14(8):4. PubMed ID: 19061564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteric-coated mycophenolate sodium - current and future use in transplant patients.
    Sollinger HW
    Expert Rev Clin Immunol; 2005 Jul; 1(2):203-11. PubMed ID: 20476934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of a generic of the immunosuppressive agent mycophenolate mofetil in pediatric patients.
    González-Ramírez R; González-Bañuelos J; Villa Mde L; Jiménez B; García-Roca P; Cruz-Antonio L; Castañeda-Hernández G; Medeiros M
    Pediatr Transplant; 2014 Sep; 18(6):568-74. PubMed ID: 24978101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mouth ulcers induced by enteric-coated mycophenolate sodium (Myfortic].
    Miquel O; Chaby G; Andrejak M; Brenet-Dufour V; Makdassi R; Denoeux JP; Lok C
    Ann Dermatol Venereol; 2007 Nov; 134(11):855-7. PubMed ID: 18033067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Review of a new immunosuppressive drug: enteric-coated mycophenolate sodium (Myfortic)].
    Sánchez-Fructuoso AI
    Nefrologia; 2005; 25(3):234-42, 244. PubMed ID: 16053004
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized calcineurin inhibitor cross over study to measure the pharmacokinetics of co-administered enteric-coated mycophenolate sodium.
    Kaplan B; Meier-Kriesche HU; Minnick P; Bastien MC; Sechaud R; Yeh CM; Balez S; Picard F; Schmouder R
    Clin Transplant; 2005 Aug; 19(4):551-8. PubMed ID: 16008604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine.
    Liu F; Lizio R; Meier C; Petereit HU; Blakey P; Basit AW
    J Control Release; 2009 Jan; 133(2):119-24. PubMed ID: 18930772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials.
    Pietruck F; Budde K; Salvadori M; Sollinger H; Bourbigot B; Gentil MA; Oppenheimer F
    Clin Transplant; 2007; 21(1):117-25. PubMed ID: 17302600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
    van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthotopic Heart Transplant Recipient with Enteric-coated Mycophenolate Sodium (Myfortic) Induced Colitis.
    Morris CC; Stroud SC; Golconda U; Gregoire SA; Juneman EB
    Am J Case Rep; 2020 May; 21():e920235. PubMed ID: 32404861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric-coated solid dosage forms containing sodium bicarbonate as a drug substance: an exception from the rule?
    Breitkreutz J; Gan TG; Schneider B; Kalisch P
    J Pharm Pharmacol; 2007 Jan; 59(1):59-65. PubMed ID: 17227621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
    Bendas ER; Ayres JW
    Eur J Pharm Biopharm; 2008 Aug; 69(3):977-85. PubMed ID: 18424095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis.
    Mak SK; Lo KY; Lo MW; Chan SF; Tong GM; Wong PN; Wong AK
    Nephrology (Carlton); 2008 Jun; 13(4):331-6. PubMed ID: 18476916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in kidney transplant patients.
    Salvadori M; Holzer H; Civati G; Sollinger H; Lien B; Tomlanovich S; Bertoni E; Seifu Y; Marrast AC;
    Clin Nephrol; 2006 Aug; 66(2):112-9. PubMed ID: 16939067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalue of two mycophenolate sodium enteric-coated tablets and the drug monitoring based on limited sampling strategy: A single-center, randomized, open-label, three-period, reference-replicated, crossover study.
    Xu G; Wang Z; Yan T; Li J; Zhou X
    Transpl Immunol; 2023 Dec; 81():101923. PubMed ID: 37652363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiochemical properties of generic formulations of tacrolimus in Mexico.
    Petan JA; Undre N; First MR; Saito K; Ohara T; Iwabe O; Mimura H; Suzuki M; Kitamura S
    Transplant Proc; 2008 Jun; 40(5):1439-42. PubMed ID: 18589125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.